
Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib
Keywords: CVD; cardiovascular disease; CHF; congestive heart failure; ctrl; control; DOX; doxycycline; ECM; Extracellular Matrix; LV; lentiviral; HFpEF; heart failure with preserved ejection function; Hgf; hepatocyte growth factor; HCM; hypertrophic cardiomyopathy;